Sensulin: AngelMD Investor Group Closes Funding Round in Sensulin LLC
The latest investment from AngelMD will go toward revolutionizing the treatment of diabetes.SEATTLE PRWEB May 23 2018 AngelMD a platform that connects medial startups with doctors that provide guidance and investors that provide funding today announced th...
Read full article »
Sensulin focuses on developing a glucose-responsive insulin to treat diabetes.
Read more